Compounds > etoposide
Page last updated: 2024-08-23

etoposide and Liposarcoma

etoposide has been researched along with Liposarcoma in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19901 (20.00)18.7374
1990's1 (20.00)18.2507
2000's1 (20.00)29.6817
2010's1 (20.00)24.3611
2020's1 (20.00)2.80

Authors

AuthorsStudies
Dizdar, L; Esposito, I; Ghadimi, MPH; Knoefel, WT; Krieg, A; Schlünder, PM; Vay, C1
Hashizume, A; Hiruma, T; Jikuya, R; Kawai, M; Kishida, T; Mizuno, N; Tatenuma, T; Umemoto, S; Yasui, M1
Atkinson, HD; Macmull, S; O'Donnell, P; Saso, S; Skinner, JA; Tirabosco, R1
Almasan, A; Banerjee, D; Bertino, JR; Fan, J; Hochhauser, D; Kelly, R; Li, W; Wahl, GM; Yin, Y; Zielinski, Z1
Roseman, JM1

Other Studies

5 other study(ies) available for etoposide and Liposarcoma

ArticleYear
Targeting abundant survivin expression in liposarcoma: subtype dependent therapy responses to YM155 treatment.
    Journal of cancer research and clinical oncology, 2022, Volume: 148, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Etoposide; Female; Follow-Up Studies; Gene Expression Regulation, Neoplastic; Humans; Imidazoles; Liposarcoma; Male; Middle Aged; Naphthoquinones; Prognosis; Retrospective Studies; Survival Rate; Survivin; Tumor Cells, Cultured

2022
[RETROPERITONEAL LIPOSARCOMA WITH MULTIPLE RECURRENCE OF LUNG METASTASES TREATED BY MULTIMODAL THERAPY CENTERING ON THE OPERATION: A CASE REPORT].
    Nihon Hinyokika Gakkai zasshi. The japanese journal of urology, 2018, Volume: 109, Issue:1

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Doxorubicin; Etoposide; Humans; Ifosfamide; Liposarcoma; Lung Neoplasms; Lymph Node Excision; Male; Neoplasm Recurrence, Local; Pneumonectomy; Retroperitoneal Neoplasms; Surgical Procedures, Operative; Thoracoscopy; Time Factors; Treatment Outcome

2018
Primary intra-osseous liposarcoma of the femur: a case report.
    Journal of orthopaedic surgery (Hong Kong), 2009, Volume: 17, Issue:3

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Cisplatin; Combined Modality Therapy; Diagnosis, Differential; Doxorubicin; Etoposide; Femoral Neoplasms; Humans; Ifosfamide; Liposarcoma; Magnetic Resonance Imaging; Male; Methotrexate; Neoadjuvant Therapy; Radiography; Whole Body Imaging

2009
Lack of functional retinoblastoma protein mediates increased resistance to antimetabolites in human sarcoma cell lines.
    Proceedings of the National Academy of Sciences of the United States of America, 1995, Oct-24, Volume: 92, Issue:22

    Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Base Sequence; Bone Neoplasms; Cell Division; Cell Line; Cisplatin; Doxorubicin; Drug Resistance, Neoplasm; Etoposide; Fibrosarcoma; Floxuridine; Humans; Liposarcoma; Methotrexate; Molecular Sequence Data; Oligonucleotide Probes; Osteosarcoma; Recombinant Proteins; Retinoblastoma Protein; Tetrahydrofolate Dehydrogenase; Thymidylate Synthase; Transfection; Tumor Cells, Cultured

1995
Effective management of extremity cancers using cisplatin and etoposide in isolated limb perfusions.
    Journal of surgical oncology, 1987, Volume: 35, Issue:3

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemotherapy, Cancer, Regional Perfusion; Cisplatin; Etoposide; Female; Humans; Leg; Liposarcoma; Male; Melanoma; Middle Aged; Soft Tissue Neoplasms

1987